JNJ - Johnson & Johnson
Johnson & Johnson Logo

JNJ - Johnson & Johnson

https://www.jnj.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Uptrend
As of 2025-09-10 (Snapshot)

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

52W High
$179.84
52W Low
$137.37
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.39
Valuation
Fair
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
18.95
Forward P/E (<15 better)
15.60
EV/EBITDA (<8 favorable)
12.85
EV/Revenue (<3 favorable)
5.05
P/S (TTM) (<3 favorable)
4.70
P/B (<3 favorable)
5.43
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
0.06%
Institutions (25–75% balanced)
74.37%
Shares Outstanding
2,408,340,000
Float
2,404,582,000
Dividend Yield (2–6% sweet spot)
0.03%
Ex‑Dividend Date
2025-08-26
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
90,626,998,000
Gross Profit (TTM)
62,000,001,000
EPS (TTM)
9.34
Profit Margin (>10% good)
0.25%
Operating Margin (TTM) (higher better)
0.29%
ROE (TTM) (>15% strong)
0.30%
EPS YoY (Quarterly) (>10% good)
0.19
Revenue YoY (Quarterly) (>8% good)
0.06
Momentum
Bearish momentum
Value
2.4503
Previous
2.5632
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025